New Immune Therapy Boosts Disease Control in Prostate Cancer
Adding an experimental immunotherapy to radiation treatment may extend disease-free survival in men with localized intermediate- or high-risk prostate cancer, according to a phase 3 trial. The treatment, which has been fast-tracked by the FDA, has two …